Hazel M. Aker's Insider Trades & SAST Disclosures
Hazel M. Aker's most recent trade in Oncternal Therapeutics Inc was a trade of 41,972 Common Stock done at an average price of $2.4 . Disclosure was reported to the exchange on July 21, 2020.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Hazel M. Aker.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Oncternal Therapeutics Inc | Hazel M. Aker | Legal Counsel | Purchase of securities on an exchange or from another person at price $ 2.38 per share. | 21 Jul 2020 | 41,972 | 46,987 (0%) | 0% | 2.4 | 99,998 | Common Stock |
| Oncternal Therapeutics Inc | Hazel M. Aker | Legal Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2020 | 20,986 | 20,986 | - | - | Warrants |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges